Target Profile
```
Patient's age must be greater than or equal to 18 years.
Patient's gender must be female.
Patient must have active diagnosis of HER2-positive carcinoma of breast.
Patient must have active diagnosis of Metastasis from malignant tumor of breast.
Patient must have historical medication with ingredient trastuzumab.
Patient must have most recent lab value of Cardiac ejection fraction method greater than or equal to 55 % AND less than or equal to 70 %.
Patient must not be pregnant.
Patient must agree to take birth control during the study.
Patient must not have historical diagnosis of symptomatic leptomeningeal carcinomatosis.
Patient must not have active medication with mechanism of action CYP450 3A4 Inducers for less than or equal to 2 weeks.
Patient must not have active medication with mechanism of action CYP450 3A4 Inhibitors for less than or equal to 2 weeks.
Patient must not have active diagnosis of Heart disease for less than or equal to 3 months.
Patient must not have active diagnosis of Heart block.
Patient must not have active diagnosis of Congestive heart failure.
Patient must not be pregnant.
Patient must not be breastfeeding.
Patient must use medical device Cardiac pacemaker.
```